Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01775254 · ClinicalTrials.gov registry record

The Inland Northwest Colon Cancer Survivor's Study

A clinical trial, sponsored by Washington State University.

Completed
Registry status
25
Enrollment target

NCT01775254: Completed study, sponsored by Washington State University.

NCT01775254 is a clinical trial that has completed, run by Washington State University. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01775254 has completed, sponsored by Washington State University.

COMPLETED
Registry status
25 participants
Enrollment target

Study Summary

The overall purpose of this study was to address the following questions by describing the trajectory of early survivorship in individuals who undergo both surgical and medical management of colon cancer. What are the changes in quality of life, demands of illness, sexual function, and peripheral neuropathy, following curative resection during the first year of treatment and recovery? Is there an interaction between exposures to chemotherapy and changes over time in these outcomes?

Primary Outcome

The European Organization for Research and Treatment Quality of Life Questionnaire

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2013-01
Est. Completion 2018-12-04
Washington State University

64 total trials

What the finished NCT01775254 record still lists

NCT01775254 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01775254 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01775254 about?

NCT01775254 is a clinical study titled "The Inland Northwest Colon Cancer Survivor's Study". The overall purpose of this study was to address the following questions by describing the trajectory of early survivorship in individuals who undergo both surgical and medical management of colon cancer. What are the changes in quality of life, demands of illness, sexual function, and peripheral ne...

What is the current status of trial NCT01775254?

This trial is currently completed. The enrollment target is 25 participants. The study started on 2013-01. Estimated completion is 2018-12-04.

Who is sponsoring clinical trial NCT01775254?

This trial is sponsored by Washington State University, which has 64 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01775254, the US trial registry maintained by the National Library of Medicine. NCT01775254 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.